Neurocrine Bioscience buy Morgan Stanley

Summary

This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -10.90%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Neurocrine Bioscience	0.399%	0.399%
iShares Core DAX®	-0.121%	2.507%
iShares Nasdaq 100	0.081%	-0.241%
iShares Nikkei 225®	-1.748%	4.105%
iShares S&P 500	-0.961%	-0.143%